| 000 | 01770 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517090818.0 | ||
| 264 | 0 | _c20170303 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1080/14656566.2016.1176148 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuérin, Annie | |
| 245 | 0 | 0 |
_aTreatment patterns and factors associated with the use of everolimus among post-menopausal women with HR+/HER2- metastatic breast cancer: a retrospective US claims study. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cJun 2016 |
||
| 300 |
_a1189-96 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdministrative Claims, Healthcare _xstatistics & numerical data |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 |
_aEverolimus _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aPractice Patterns, Physicians' _xstatistics & numerical data |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aAssessment of Medication Adherence |
| 700 | 1 | _aHao, Yanni | |
| 700 | 1 | _aTang, Derek | |
| 700 | 1 | _aPeeples, Miranda | |
| 700 | 1 | _aFang, Anna | |
| 700 | 1 | _aKageleiry, Andrew | |
| 700 | 1 | _aKoo, Valerie | |
| 700 | 1 | _aLi, Nanxin | |
| 700 | 1 | _aWu, Eric Q | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 17 _gno. 9 _gp. 1189-96 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14656566.2016.1176148 _zAvailable from publisher's website |
| 999 |
_c25900755 _d25900755 |
||